B26.84 Mumps polyneuropathy

Name of the Condition

• Mumps polyneuropathy

Summary

Mumps polyneuropathy refers to peripheral nerve involvement resulting from mumps virus infection, a complication of mumps. This condition involves neurological manifestations beyond the typical parotid gland swelling associated with mumps. The polyneuropathy may occur alongside or after primary mumps symptoms, requiring specific clinical evaluation and management.

Causes

Mumps polyneuropathy is caused by the mumps virus, an RNA virus from the Paramyxoviridae family. The virus spreads through respiratory droplets or direct contact with infected saliva. Polyneuropathy develops when the virus affects peripheral nerves, leading to inflammation and potential nerve dysfunction.

Risk Factors

• Lack of vaccination against mumps.
• Close contact with an infected individual.
• Immunocompromised states, such as HIV/AIDS or chemotherapy.
• Age, with adolescents and young adults at higher risk for complications.
• Underlying neurological conditions that may predispose to severe infection.

Symptoms

• Swelling and tenderness of one or both parotid glands (salivary glands).
• Fever.
• Headache.
• Muscle aches.
• Fatigue.
• Loss of appetite.
• Numbness or tingling in the hands or feet (polyneuropathy).
• Weakness in the limbs.
• Difficulty with coordination or balance.
• Pain or burning sensations in the affected areas.

Diagnosis

Diagnosis is typically based on clinical evaluation, including a history of mumps infection and neurological symptoms. Laboratory tests may include viral serology to confirm mumps exposure. Nerve conduction studies or electromyography (EMG) can assess nerve function. Imaging or other tests may be used to rule out other causes of neuropathy.

Treatment Options

Treatment focuses on managing symptoms and supporting recovery. This may include pain relief for neuropathic symptoms, physical therapy to maintain mobility, and monitoring for complications. Antiviral therapy is not typically used for mumps polyneuropathy, as the virus is usually cleared by the immune system. Supportive care, such as rest and hydration, is important during the acute phase.

Prognosis and Follow-Up

Prognosis varies depending on the severity of nerve involvement. Many patients experience gradual improvement over weeks to months, but some may have persistent symptoms. Follow-up with a healthcare provider is important to monitor recovery and address any long-term effects. Rehabilitation or specialist care may be needed for significant weakness or functional impairment.

Complications

Potential complications include persistent neuropathic pain, chronic weakness, or reduced sensation in affected areas. In rare cases, severe nerve damage could lead to permanent disability. Other mumps complications, such as orchitis or meningitis, may occur concurrently and require additional management.

Lifestyle & Prevention

Prevention of mumps polyneuropathy primarily involves vaccination against mumps, which reduces the risk of infection and its complications. Good hygiene, such as handwashing and avoiding close contact with infected individuals, can help prevent spread. For those with mumps, rest and adequate hydration support recovery and may reduce the risk of severe complications.

When to Seek Professional Help

Seek medical attention if you experience new or worsening neurological symptoms, such as sudden weakness, numbness, or difficulty with coordination, especially after a mumps infection. Prompt evaluation is important to rule out serious complications and initiate appropriate care.

Tips for Medical Coders

When coding for mumps polyneuropathy, use the ICD-10-CM code B26.84. Ensure documentation supports the diagnosis, including evidence of mumps infection and neurological symptoms consistent with polyneuropathy. Verify that the code is not used for other mumps complications or unrelated neuropathies. Follow coding guidelines for sequencing and specificity.